JP Morgan Life Sciences Private Capital

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

JP Morgan Life Sciences Private Capital — overview

Type

Private Equity Firm

Location

New York, NY, US

Alternative Asset Class

PE

Established

-

Firm Ownership

-

Investment Team Staff

Total Staff

-

About

JP Morgan Life Sciences Private Capital is a private equity firm invest in early-stage biotherapeutics and late-stage healthcare companies, founded in late 2022.
Asset ClassNo. of Funds Currently ManagedFunds Raised in the last 10 yearsEst. Dry PowderStrategies
Private Equity--
Private Debt--
Real Estate--
Infrastructure--
Natural Resources--
Asset ClassNo. of Funds Currently ManagedAuMDate of AuMStrategies
Hedge Funds--

Want to see more?

Request a demo for full access to this profile.

JP Morgan Life Sciences Private Capital - known decision makers (1)

Contact NamePositionLocationEmailTelephoneAsset Class
Life Sciences Growth InvestorNew York, USPE

Showing 1 of 1 known decision makers JP Morgan Life Sciences Private Capital

Preqin screens the most influential contacts in alternatives, so you only reach the key decision makers

Request a demo to see more

Performance track records at your fingertips

Access effective, reliable, and comparable fund performance data and place your firm or portfolio within the context of the alternative assets market.

With data and benchmarks that track back more than 40 years, Preqin Pro is the most trusted data provider in the industry.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.